Skip to main content

Table 1 Baseline characteristics

From: Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial

Characteristic N (%)
Age(y)
 Median (IQR) 65 (61–70)
Sex
 Male 77 (71%)
 Female 31 (29%)
Stage (AJCC, 6th)
 IIb 19 (17%)
 III 59 (55%)
 IVa 30 (28%)
Tumor length, cm
 < 5 53 (49%)
 ≥ 5 55 (51%)
Tumor location
 Upper (< 25 cm) 57 (53%)
 Middle (25-30 cm) 33 (30%)
 Lower (> 30 m) 15 (14%)
 Multiple primary 3 (3%)
ECOG performance score
 0 101 (94%)
 1 7 (6%)
Chronic disease history
 Yes 39 (36%)
 No 69 (64%)
Smoking history
 Former or current 58 (54%)
 Never 50 (46%)
Drinking history
 Former or current 53 (49%)
 Never 55 (51%)
  1. IQR inter-quartile range